Title: R&I: Chemotherapy Induced Peripheral Neuropathy Market - Size, Share, Global Trends, 2014
1 Chemotherapy Induced Peripheral Neuropathy Global
Clinical Trials Review, H2, 2014
No of pages 129
Publish Date October 2014
2Description
GlobalData's clinical trial report, Chemotherapy
Induced Peripheral Neuropathy Global Clinical
Trials Review, H2, 2014" provides data on the
Chemotherapy Induced Peripheral Neuropathy
clinical trial scenario. This report provides
elemental information and data relating to the
clinical trials on Chemotherapy Induced
Peripheral Neuropathy. It includes an overview of
the trial numbers and their recruitment status as
per the site of trial conduction across the
globe. The databook offers a preliminary
coverage of disease clinical trials by their
phase, trial status, prominence of the sponsors
and also provides briefing pertaining to the
number of trials for the key drugs for treating
Chemotherapy Induced Peripheral Neuropathy. This
report is built using data and information
sourced from proprietary databases, primary and
secondary research and in-house analysis by
GlobalData's team of industry experts. Complete
report is available at http//www.reportsandint
elligence.com/chemotherapy-induced-peripheral-neur
opathy-global-clinical-trials-review-h2-2014-marke
t
3Description
- Scope
- Data on the number of clinical trials conducted
in North America, South and Central America,
Europe, Middle-East and Africa and Asia-pacific
and top five national contributions in each,
along with the clinical trial scenario in BRIC
nations - Clinical trial (complete and in progress) data by
phase, trial status, subjects recruited and
sponsor type - Listings of discontinued trials (suspended,
withdrawn and terminated)Reasons to buy - Understand the dynamics of a particular
indication in a condensed manner - Abridged view of the performance of the trials in
terms of their status, recruitment, location,
sponsor type and many more - Obtain discontinued trial listing for trials
across the globe - Espy the commercial landscape of the major
Universities / Institutes / Hospitals or
Companies
4Table Of Content
- Introduction
- Chemotherapy Induced Peripheral Neuropathy
- Report Guidance
- Clinical Trials by Region
- Clinical Trials and Average Enrollment by Country
- Top Five Countries Contributing to Clinical
Trials in Asia-Pacific - Top Five Countries Contributing to Clinical
Trials in Europe - Get full TOC at http//www.reportsandintelligence
.com/chemotherapy-induced-peripheral-neuropathy-gl
obal-clinical-trials-review-h2-2014-market/table-o
f-contents
5 FOR MORE DETAILS
Visit us at
http//www.reportsandintelligence.com/chemotherapy
-induced-peripheral-neuropathy-global-clinical-tri
als-review-h2-2014-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE Direct 1 (617) 674-4143 Toll Free
1 (855) 711-1555E-MAIL sales_at_reportsandintellig
ence.com